MIR96-IN-1

For research use only. Not for therapeutic Use.

  • CAT Number: I001196
  • CAS Number: 1311982-88-3
  • Molecular Formula: C33H48N8O2
  • Molecular Weight: 588.79
  • Purity: ≥95%
Inquiry Now

MIR96-IN-1(Cat No.:I001196)is a selective inhibitor targeting the methyltransferase SETD8, which is responsible for monomethylating histone H4 at lysine 20 (H4K20me1). By inhibiting SETD8, MIR96-IN-1 disrupts the epigenetic regulation of gene expression, potentially leading to the reactivation of silenced tumor suppressor genes. This compound has shown promise in preclinical studies, particularly in cancer models where aberrant SETD8 activity contributes to tumorigenesis. MIR96-IN-1’s ability to modulate histone methylation provides valuable insights into developing targeted therapeutic strategies aimed at addressing epigenetic alterations in various cancers.


Catalog Number I001196
CAS Number 1311982-88-3
Molecular Formula C33H48N8O2
Purity ≥95%
Target microRNA-96
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name N-(3-azidopropyl)-4-[2,6-ditert-butyl-4-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]phenoxy]butanamide
InChI InChI=1S/C33H48N8O2/c1-32(2,3)25-20-23(31-37-27-12-11-24(22-28(27)38-31)41-17-15-40(7)16-18-41)21-26(33(4,5)6)30(25)43-19-8-10-29(42)35-13-9-14-36-39-34/h11-12,20-22H,8-10,13-19H2,1-7H3,(H,35,42)(H,37,38)
InChIKey LTPQCIXFOJELHJ-UHFFFAOYSA-N
SMILES CC(C)(C)C1=CC(=CC(=C1OCCCC(=O)NCCCN=[N+]=[N-])C(C)(C)C)C2=NC3=C(N2)C=C(C=C3)N4CCN(CC4)C
Reference

<p style=/line-height:25px/>
<br>[1]. Velagapudi SP, et al. Sequence-based design of bioactive small molecules that target precursor microRNAs. Nat Chem Biol. 2014 Apr;10(4):291-7.
<br>[2]. Haga CL, et al. Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling. ACS Chem Biol. 2015 Oct 16;10(10):2267-76.
<br>[3]. Velagapudi SP, et al. Defining the RNA internal loops preferred by benzimidazole derivatives via 2D combinatorial screening and computational analysis. J Am Chem Soc. 2011 Jul 6;133(26):10111-8.
</p>

Request a Quote